The heart was recovering. Both mother and child survived what could easily have been fatal.
At the intersection of obstetric urgency and cardiac catastrophe, a 36-year-old woman carrying a near-term child arrived at a tertiary hospital with a heart functioning at a quarter of its capacity, a clot in her atrium, and a pulse racing toward collapse. What followed was not a single heroic act but a carefully orchestrated convergence of disciplines—each decision weighted against the possibility that the next might be the last available. That both mother and child left the hospital twelve days later speaks less to the triumph of technology than to the quiet power of preparation, humility before uncertainty, and the willingness to act when waiting becomes its own form of harm.
- A woman whose years of inconsistent treatment had quietly eroded her heart arrived in near-cardiovascular collapse at 32 weeks pregnant, leaving her care team with minutes to prevent the irreversible.
- Every standard protocol carried its own lethal trap: the preferred anesthesia risked a spinal bleed, cardioversion risked a stroke, and surgery itself risked the cardiac arrest that ECMO cannulas were preemptively staged to address.
- When drugs failed to slow a heart racing at 190 beats per minute and blood pressure fell into the 60s, the team chose electrical cardioversion despite residual embolic uncertainty—a calculated gamble that converted chaos into rhythm.
- The crisis did not end in the operating room; cardiogenic shock deepened overnight, kidneys failed, and only continuous renal replacement therapy and falling vasopressor doses over subsequent days signaled that the body was beginning to reclaim itself.
- By day four, an ejection fraction of 52 percent—double what it had been on arrival—revealed that the underlying damage was reversible, the consequence of uncontrolled thyroid disease rather than permanent structural loss.
A 36-year-old woman arrived at a regional hospital having fainted, her heart in atrial fibrillation and her lungs drowning in fluid. She was 32 weeks pregnant. Transferred urgently to a cardiac center, she carried a history of undertreated hyperthyroidism and intermittent medication compliance that had quietly dismantled her cardiovascular health over years. Her ejection fraction stood at 25 percent. A clot floated in her right atrium. Her pulse ran between 160 and 170 beats per minute. Doctors had very little time.
The multidisciplinary team—cardiologists, obstetricians, anesthesiologists, and cardiothoracic surgeons—determined that the cesarean delivery was primarily a maternal intervention; the baby's heart rate remained stable, but the mother's heart could not wait. Epidural anesthesia, normally preferred for cardiac patients, was ruled out because full anticoagulation would be required immediately after delivery to address the atrial clot, creating an unacceptable risk of spinal hemorrhage. General anesthesia was chosen instead. Before the patient entered the operating room, a cardiothoracic surgeon placed guidewires in her femoral vessels so that ECMO could be initiated within minutes if her heart failed during surgery.
The baby was delivered four minutes after induction, weighing 2.29 kilograms. Almost immediately, the mother's blood pressure collapsed. Vasopressors were administered. Her heart rate climbed to 190 beats per minute, still in fibrillation. Amiodarone failed to restore rhythm. A transesophageal echocardiogram found no definitive clot in the left atrium, and the team—judging the immediate danger of shock to outweigh the theoretical risk of embolism—delivered a synchronized electrical shock. The heart converted. Blood pressure stabilized. The ECMO cannulas were never deployed.
The hours that followed were not straightforward. Cardiogenic shock deepened overnight, kidney function deteriorated, and continuous renal replacement therapy was required. Gradually, vasopressor support was reduced. She was extubated on day two. On day four, echocardiography revealed an ejection fraction of 52 percent—a recovery that pointed toward tachycardia-induced cardiomyopathy driven by uncontrolled hyperthyroidism, a condition capable of reversing when treated in time. Both mother and infant were discharged on day twelve, the child having gained weight in the neonatal unit, the mother leaving on anticoagulation and optimized cardiac medications. What had arrived as near-certain catastrophe departed as a measured, if fragile, survival.
A 36-year-old woman arrived at the hospital at 32 weeks pregnant, gasping for breath and on the edge of collapse. Her heart was barely working—an ejection fraction of 25 percent, meaning her left ventricle was pumping at a quarter of normal capacity. Her heart was also racing erratically in atrial fibrillation, her pulse hitting 160 to 170 beats per minute. Scans showed a blood clot floating in her right atrium. She had fainted earlier that day. By any standard measure, she was in near-catastrophic condition, and her doctors had hours, maybe minutes, to decide what to do.
The woman's troubles had been building for years. In 2020, she was diagnosed with an overactive thyroid but took her medication only sporadically. Two years later, she developed atrial fibrillation and heart failure, prescribed digoxin and bisoprolol—drugs she also took inconsistently. During pregnancy, she was taking her beta-blocker only when she remembered, and she was not on any blood thinner despite her irregular heartbeat. By 28 weeks, she was struggling to breathe. At 32 weeks, doctors drained a liter of excess fluid from around her lungs to give her temporary relief, but within hours the breathlessness returned and worsened. When she fainted at a regional hospital, she was rushed to a tertiary cardiac center.
The multidisciplinary team—obstetricians, cardiologists, anesthesiologists, and cardiothoracic surgeons—gathered to plan an emergency cesarean delivery. The decision was not primarily about the baby, whose heart rate remained reassuring. It was about the mother. Cardiologists believed that waiting any longer risked sudden cardiovascular collapse. But the surgery itself posed enormous danger. Normally, doctors prefer epidural anesthesia for cardiac patients undergoing cesarean delivery because it can be carefully titrated to maintain stable blood pressure. In this case, that option was off the table. The team knew they would need to start full-dose blood thinners immediately after delivery to prevent stroke from the atrial clot. An epidural catheter left in the spine while the patient was on aggressive anticoagulation could cause a catastrophic spinal bleed. General anesthesia it would be, despite its own risks.
The team prepared for the worst. Before the patient even entered the operating room, the cardiothoracic surgeon placed guidewires in her femoral artery and vein—a preemptive setup that would allow them to cannulate her for ECMO, a heart-lung bypass machine, within minutes if her heart gave out during surgery. The surgeon would stand by throughout the procedure. Invasive monitoring lines were placed. The anesthesiologist prepared to use transesophageal echocardiography—a probe inserted down the throat to visualize the heart in real time—to guide decisions.
The baby was delivered four minutes after anesthesia induction, weighing 2.29 kilograms. But immediately after the uterotonic drug was given to contract the uterus, the mother's blood pressure collapsed into the 60s. Vasopressors were pushed, then infusions started. The heart rate climbed to 190 beats per minute, still in chaotic atrial fibrillation. Amiodarone was given to try to restore normal rhythm, but the drugs were not working. The team performed the transesophageal echo to check for a clot in the left atrium—if one was present, electrical cardioversion could dislodge it and cause a stroke. The probe showed severe dysfunction in both ventricles, severe leaking of the mitral and tricuspid valves, and the right atrial clot, but no definite left atrial thrombus. Given that the mother was in shock and the tachycardia was driving her toward death, the team decided the immediate threat outweighed the theoretical embolic risk. They delivered 100 joules of synchronized electrical shock. The heart converted to normal sinus rhythm. Blood pressure began to stabilize.
The ECMO cannulas were never needed. The femoral guidewires were removed. The mother was transferred to the cardiac intensive care unit on a ventilator. Over the next 24 hours, her condition deteriorated again—cardiogenic shock deepened, kidney function failed, acid accumulated in her blood. Continuous kidney replacement therapy was started to clear metabolic waste and manage fluid. Slowly, over days, the vasopressor doses came down. She was extubated on day two. By day four, a repeat echocardiogram showed something remarkable: her ejection fraction had improved to 52 percent. The heart was recovering. The likely culprit was tachycardia-induced cardiomyopathy from her uncontrolled hyperthyroidism, worsened by pregnancy's demands on the cardiovascular system—a condition that could reverse if caught and treated in time. She was discharged on day 12 on optimized heart failure medications and anticoagulation. The baby, after a brief stay in the neonatal intensive care unit, was discharged at day 12 as well, weighing 2.4 kilograms. Both mother and child survived what could easily have been fatal.
Notable Quotes
Cardiologists believed that waiting any longer risked sudden cardiovascular collapse.— Clinical team assessment
The likely culprit was tachycardia-induced cardiomyopathy from her uncontrolled hyperthyroidism, worsened by pregnancy's demands—a condition that could reverse if caught and treated in time.— Clinical analysis
The Hearth Conversation Another angle on the story
Why did the team choose general anesthesia when epidural is usually safer for the heart?
Because she needed blood thinners immediately after delivery. An epidural catheter in the spine while on full anticoagulation is a recipe for spinal bleeding. They had to choose between two bad options and picked the one that wouldn't paralyze her spine.
The cardioversion—that's electrical shock to the heart. Wasn't that dangerous with a clot in the atrium?
Extremely dangerous. That's why they did the ultrasound probe down her throat first. They needed to know if there was a clot in the left side of the heart, because shocking it could send that clot to her brain. They found one on the right side but not the left, so they made the call: she's dying right now from this rhythm, and the risk of waiting is worse than the risk of shocking.
What changed between day one and day four? Why did her heart suddenly start working again?
It wasn't sudden, but it was fast. Her heart wasn't permanently broken—it was being strangled by a racing pulse driven by an overactive thyroid she wasn't treating. Once they slowed the heart down and took the pregnancy stress away by delivering the baby, the muscle could recover. It's reversible if you catch it in time.
The ECMO setup—they placed those cannulas before surgery but never used them. Was that wasted preparation?
No. That preparation bought them time and psychological safety. If her heart had truly failed, they could have been on bypass in minutes instead of the hour it would take to set up from scratch. In a crisis, minutes are the difference between life and death. The fact that they didn't need it doesn't mean it wasn't essential.
What would have happened if she'd waited another week to deliver?
The cardiologists said she would have collapsed. Her heart was compensating on fumes. Pregnancy keeps adding volume and demand to the circulation. At some point, the system breaks. They delivered her as a rescue, not because the baby needed it, but because the mother couldn't survive another day.